Katie Ludwig FY1.   50, 285 New cases of breast cancer - 2011  11, 716 deaths - 2012  78% - 10 year survival rates  27% preventable cases  Source:

Slides:

Advertisements

Similar presentations

Mammary ductal carcinoma

Advertisements

North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.

DCIS – Are we cutting it? Dr Alex Lemaigre With thanks to:

AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.

Development of laboratory models to study Breast Cancer Deborah Holliday Breast Research Group Section of Pathology & Tumour Biology Section of Pathology.

Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis

Breast Cancer Screening, Family History Assessment and New Innovations Miss Karina Cox Consultant Breast and Oncoplastic Surgeon.

BREAST CANCER AWARENESS OCTOBER IS THE MONTH THIS IS INFO ABOUT GLOBAL USA MASSACHUSETTS and its COUNTIES.

Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.

By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.

Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.

Margins: less is just as good

Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.

The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.

Recent advances in MRI Breast and Future

Breast Cancer Screening Beyond 70 Years Old Henry Kwok Breast Imaging Fellow BreastScreen Aotearoa Counties Manukau.

Non-Invasive Breast Cancer: Non-Invasive Breast Cancer: Ductal Carcinoma In-situ Vassi Gardikas, MD, FACS Ellen Malek, CTR 2011 Oncology Services Annual.

The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.

Ductal Carcinoma in situ

Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA

Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,

How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.

Dilemma in management of DCIS

Ductal Carcinoma In Situ (DCIS)

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.

Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Management of DCIS KWH Experience Dr. Carmen Ho.

Pan-Birmingham Cancer Network NCAT Commissioning Exemplar Breast Cancer Surgery 4 th November 2010.

Breast Cancer By: Christen Scott.

TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.

Leiomyosarcoma of the Vulva Bapir M, Hoh J & Al-Inizi S

Radiotherapy vs. No Radiotherapy after breast conserving surgery (BCS) for in-situ breast cancer. Luc Vakaet.

EUNICE Breast Screening Monitoring User guide

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Surgical Oncology Surgical Oncology 05/06/12 – 05/12/2012 David Williams Andy Young Ashley Limkemann Yula Dzhashiashvili.

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

Surgical Oncology Surgical Oncology 04/21/12 – 04/27/2012 David Williams Andy Young Justin Brown Xi Bei Tian Jonathan Young.

Breast Tumors Diagnosed as Papillary Neoplasm by FNAB Dae-Kyum Kim, Sang-Uk Woo, Jeong-Han Kim, Seok-Jin Nam, Yoon-La Choi 1, Young-Lyun Oh 1 and Jung-Hyun.

Radiotherapy Protocols Bristol protocol version 12.

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in

Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service

BREAST BRACHYTHERAPY OUTCOMES EVALUATION Margaret Pierce DNP, APRN, BC University of Tennessee Knoxville, Tennessee.

Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.

The New trends in the Management of Breast Cancer 謝渙發桃園縣醫師公會監事怡仁綜合醫院副院長教育部部定助理教授國防醫學院外科學系臨床教授.

Breast Surgery in Delhi Breast Cancer Epidemiology Halsted Theory Radical Mastectomy Fisher Theory Modified Radical Mastectomy Goals of Breast Conservation.

Squamous Cell Carcinoma

Case 3 Jane McNicholas Consultant Oncoplastic Breast Surgeon

Operative Approach and

Copyright © 2013 American Medical Association. All rights reserved.

Breast conserving surgery (BCT): Every millimetre counts

Ductal Carcinoma (Breast Cancer)

Daniel Keith – Dermatology Registrar

Audit of Results of Lid Tumour Excision

But how to treat those with positive SLNB? Results and Discussion

SPECIMEN SONOGRAM - Procedure

1st UK Interdisciplinary Breast Cancer Symposium

Mastectomy and Reconstruction In Asian Breast Cancer Patients

Stamatia Destounis, MD, FACR, FSBI, FAIUM

Breast Cancer Guideline Update – Sharp Focus on Who is at Risk

Assessment of Breast and Colorectal Cancer Surgery in Manitoba

SCC MDT Service Evaluation

Presentation transcript:

Katie Ludwig FY1

  50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source: Cancer Research UK Background

  58% of women diagnosed with breast cancer opt for breast conserving surgery  1 in 5 women with breast cancer who have opted for breast conserving surgery rather than mastectomy go on to have reoperation  Source: British Medical Journal (2012) After Diagnosis

  2mm radial margin of excision is recommended  Microscopically review  Consider re-excision if margin in <2mm  Source: NICE Guidelines (“ Early and Locally Advanced Breast Cancer” 2009 ) Wide Local Excision (WLE)

  156 NHS trusts  55, 297 women had breast conserving surgery  20% had at least one re-operation  Reoperation rate % in carcinoma in situ, 18% isolated invasive cancer.  40% underwent further mastectomy  Source: (BMJ “Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics” 2012) Our Benchmark Study

  Anonymous data collected from Medway  Between: 01/04/ /08/2013  The study considered patients who had WLE then went onto have further re-excision  Does not count subsequent operation to axilla  Only included re-operations ipsilateral to original WLE due to histological finding of close borders and NOT early recurrence Collection Method

  77 patient had WLE  14 (18%) had further surgery (mastectomy or further breast conserving surgery)  8 (57%) had further excision.  6 (43%) had mastectomy Results

  11 had bigger tumour on histology than indicated on radiology  1 tumour was smaller on histological review  8 (57%) had cavity shaves on first operation  In comparison: 17/63 (27%) who did not have re- excision had cavity shaves Of the 14 that had further surgery

  8 underwent further excision  6 had mastectomy after initial WLE (43%)  Reasons why patient had mastectomy:  Two or more close margins on histology (2 cases)  Extensive lymph node involvement (2 cases)  Large tumour already excised and margins still close (1 case)  One case of Squamous cell ca. extending posteriorly Re-excision: Mastectomy vs. WLE

  8 had Invasive Ductal Carcinoma (IDC)  4 had IDC with Ductal Carcinoma In Situ (DCIS) on either on margin or foci away from main site.  1 case of mucinous carcinoma with DCIS foci away from main lesion  1 case of squamous cell carcinoma Histology

  Re-operation rate: 18%  Further operation: 43% - mastectomy, 57% - Further breast conserving surgery  Within the whole study: further excision rate is 10 % and mastectomy rate is 8% Summary

  Nearly all had tumour sizes were underestimated on radiology  Comparable re-operation rates with the cohort study  Marginally higher mastectomy rates after initial operation  Patients the risk of re-operation Conclusions

  Mr. N Rahman  Mr. P Arora  Mr. S Ellenbogen  Mr. A Dhebri  Mr. S Sabri Thank You